Please try another search
The objective of the Sub-Fund is to achieve growth by investing at least two-thirds (2/3) of its net assets in Transferable Securities issued by biopharmaceutical companies that are at the forefront of innovation in the medical sector.
Name | Title | Since | Until |
---|---|---|---|
Not Disclosed | - | 2014 | 2024 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review